1. Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group. Issue 12 (December 2017) Authors: Eichenauer, Dennis A; Plütschow, Annette; Kreissl, Stefanie; Sökler, Martin; Hellmuth, Johannes C; Meissner, Julia; Mathas, Stephan; Topp, Max S; Behringer, Karolin; Klapper, Wolfram; Kuhnert, Georg; Dietlein, Markus; Kobe, Carsten; Fuchs, Michael; Diehl, Volker; Engert, Andreas; Borchmann, Peter Journal: Lancet oncology Issue: Volume 18:Issue 12(2017:Dec.) Page Start: 1680 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14). Issue 4 (April 2021) Authors: Gillessen, Sarah; Plütschow, Annette; Fuchs, Michael; Markova, Jana; Greil, Richard; Topp, Max S; Meissner, Julia; Zijlstra, Josée M; Eichenauer, Dennis A; Bröckelmann, Paul J; Diehl, Volker; Borchmann, Peter; Engert, Andreas; von Tresckow, Bastian Journal: Lancet Issue: Volume 8:Issue 4(2021) Page Start: e278 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial. Issue 6 (June 2021) Authors: Kreissl, Stefanie; Goergen, Helen; Buehnen, Ina; Kobe, Carsten; Moccia, Alden; Greil, Richard; Eichenauer, Dennis A; Zijlstra, Josée M; Markova, Jana; Meissner, Julia; Feuring-Buske, Michaela; Soekler, Martin; Beck, Hans-Joachim; Willenbacher, Wolfgang; Ludwig, Wolf-Dieter; Pabst, Thomas; Topp, M... Journal: Lancet Issue: Volume 8:Issue 6(2021) Page Start: e398 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group. Issue 10114 (23rd December 2017) Authors: Borchmann, Peter; Goergen, Helen; Kobe, Carsten; Lohri, Andreas; Greil, Richard; Eichenauer, Dennis A; Zijlstra, Josée M; Markova, Jana; Meissner, Julia; Feuring-Buske, Michaela; Hüttmann, Andreas; Dierlamm, Judith; Soekler, Martin; Beck, Hans-Joachim; Willenbacher, Wolfgang; Ludwig, Wolf-Dieter;... Journal: Lancet Issue: Volume 390:Issue 10114(2017) Page Start: 2790 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Pharmacokinetics of remdesivir in a COVID-19 patient with end-stage renal disease on intermittent haemodialysis. (30th November 2020) Authors: Sörgel, Fritz; Malin, Jakob J; Hagmann, Henning; Kinzig, Martina; Bilal, Muhammad; Eichenauer, Dennis A; Scherf-Clavel, Oliver; Simonis, Alexander; El Tabei, Lobna; Fuhr, Uwe; Rybniker, Jan Journal: Journal of antimicrobial chemotherapy Issue: Volume 76:Number 3(2021) Page Start: 825 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Pharmacotherapy of Hodgkin lymphoma: standard approaches and future perspectives. (June 2014) Authors: Eichenauer, Dennis A; Böll, Boris; Diehl, Volker Journal: Expert opinion on pharmacotherapy Issue: Volume 15:Number 8(2014) Page Start: 1139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Pharmacotherapy of Hodgkin lymphoma: standard approaches and future perspectives. (June 2014) Authors: Eichenauer, Dennis A; Böll, Boris; Diehl, Volker Journal: Expert opinion on pharmacotherapy Issue: Volume 15:Number 8(2014) Page Start: 1139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗